Matthew Gline

Affiliations

  • Ceo at Roivant Sciences Ltd. (ROIV), 2025-05-23
  • Large Shareholder, Director at Arbutus Biopharma Corp (ABUS), 2025-03-06
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ROIV $11.79 1,983,257 $23,382,600.03 17,870,543 2024-09-23 Filing
ROIV $4.40 19,276 $84,814.40 1,164,009 2022-10-25 Filing
ROIV $3.07 21,053 $64,632.71 1,183,285 2022-09-23 Filing
ROIV $3.71 20,009 $74,233.39 1,204,338 2022-08-24 Filing
ROIV $4.33 20,455 $88,570.15 1,224,347 2022-07-25 Filing